NIH Funding Opportunities and Notices

NIBIB is passing along the weekly NIH Guide for Grants and Contracts Table of Contents. Scroll down for information and opportunities that may be of interest. Weekly NIH Funding Opportunities and Notices NIH Guide for Grants and Contracts February 26, 2021   General Notices Notice of Information: Submission of NIAID Investigator-Initiated Clinical Trials to Appropriate FOAs (NOT-AI-21-037) National Institute of Allergy and Infectious Diseases Notice of Pre-Application Webinar for Gabriella Miller Kids First Pediatric Research Program RFA-RM-21-011: Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed) (NOT-RM-21-020) Office of Strategic Coordination (Common Fund) Notices of Changes to Funding Opportunities Notice of National Institute on Alcohol Abuse and Alcoholism (NIAAA) Participation in PAR-21-144, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 BESH Required)" (NOT-AA-21-006) National Institute on Alcohol Abuse and Alcoholism Notice of National Institute on Alcohol Abuse and Alcoholism (NIAAA) Participation in PAR-21-145, Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Clinical Trials Not Allowed) (NOT-AA-21-007) National Institute on Alcohol Abuse and Alcoholism Notice of Change to Award Information in PAR-20-108, "International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) (NOT-AI-21-038) National Institute of Allergy and Infectious Diseases Notice of NEI Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)" (NOT-EY-21-008) National Eye Institute Notice of NICHD Participation in RFA-DA-21-020 "HEAL Initiative: HEALthy Brain and Child Development Study (Collaborative U01- Clinical Trial Not Allowed)" (NOT-HD-21-010) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of NICHD Participation in RFA-DA-21-021 "HEAL Initiative: HEALthy Brain and Child Development Study (U01 - Clinical Trial Not Allowed)" (NOT-HD-21-011) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of NICHD Participation in RFA-DA-21-022 "HEAL Initiative: HEALthy Brain and Child Development Consortium Administrative Core (U24 - Clinical Trial Not Allowed)" (NOT-HD-21-012) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of NICHD Participation in RFA-DA-21-023 "HEAL Initiative: HEALthy Brain and Child Development Data Coordinating Center (U24)" (NOT-HD-21-013) Eunice Kennedy Shriver National Institute of Child Health and Human Development Notice of Change to Participation for RFA-MH-20-620, "BRAIN Initiative Fellows: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32)" (NOT-MH-21-200) National Institute of Mental Health National Cancer Institute National Eye Institute Notice of Expiration of RFA-RM-20-023 "NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed)" (NOT-RM-21-018) Office of Strategic Coordination (Common Fund) Notices of Intent to Publish Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Disease Teams for Rheumatoid Arthritis, Lupus, Psoriatic Spectrum Diseases and Sjogrens Syndrome (UC2 Clinical Trial Optional) (NOT-AR-21-013) National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Allergy and Infectious Diseases National Institute of Dental and Craniofacial Research Office of Research on Women's Health Notice of Intent to Publish a Funding Opportunity Announcement for Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases: Technology and Analytic Cores (TACs) and Research Management Unit (RMU) (UC2) (Clinical Trials Not Allowed) (NOT-AR-21-014) National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Allergy and Infectious Diseases National Institute of Dental and Craniofacial Research Office of Research on Women's Health Notice of Intent to Publish a Funding Opportunity Announcement for Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional) (NOT-MD-21-016) National Institute on Minority Health and Health Disparities National Center for Complementary and Integrative Health National Cancer Institute National Eye Institute National Human Genome Research Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute on Deafness and Other Communication Disorders National Institute of Dental and Craniofacial Research National Institute of Environmental Health Sciences National Institute of General Medical Sciences National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institute of Nursing Research Office of Behavioral and Social Sciences Research Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Black Children and Adolescents (R01 Clinical Trial Optional) (NOT-MH-21-185) National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Black Children and Adolescents (R34 Clinical Trial Optional) (NOT-MH-21-186) National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Youth from Underserved Populations (R01 Clinical Trial Optional) (NOT-MH-21-187) National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for Systems-Level Risk Detection and Interventions to Reduce Suicide Ideation and Behaviors in Youth from Underserved Populations (R34 Clinical Trial Optional) (NOT-MH-21-188) National Institute of Mental Health Notice of Intent to Publish a Funding Opportunity Announcement for NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (NOT-NS-21-030) National Institute of Neurological Disorders and Stroke National Eye Institute National Institute of Allergy and Infectious Diseases National Institute of Arthritis and Musculoskeletal and Skin Diseases National Institute on Drug Abuse Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) (NOT-NS-21-031) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Mental Health Office of Behavioral and Social Sciences Research Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) (NOT-NS-21-032) National Institute of Neurological Disorders and Stroke National Center for Complementary and Integrative Health National Eye Institute National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute of Biomedical Imaging and Bioengineering Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute on Drug Abuse National Institute of Dental and Craniofacial Research National Institute of Mental Health Office of Behavioral and Social Sciences Research Requests for Proposal Request for Proposals (RFP) Notice: Development & Manufacture of Pharmaceutical Products for the Treatment of Substance Abuse Disorders (NOT-DA-21-031) National Institute on Drug Abuse Notices of Special Interest Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration (NOT-AG-21-016) National Institute on Aging Notice of Special Interest (NOSI): Using Data to Advance HIV Epidemic Knowledge and Program Planning (NOT-DA-21-007) National Institute on Drug Abuse Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health (NOT-EB-21-001) National Institute of Biomedical Imaging and Bioengineering National Center for Advancing Translational Sciences National Human Genome Research Institute National Heart, Lung, and Blood Institute National Institute of Allergy and Infectious Diseases Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institute of Mental Health National Institute on Minority Health and Health Disparities National Institute of Neurological Disorders and Stroke Office of the Director, NIH Office of Research on Women's Health Notice of Special Interest (NOSI): Administrative Supplements to STTR Regional Technology Transfer Accelerator Hubs to Provide Instruction in Business Fundamentals to Core Facility Directors (NOT-GM-21-017) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (NOT-GM-21-019) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Activities to Enhance Wellness and Resiliency in the Training Environment (NOT-GM-21-022) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Activities to Enhance Mentoring in the Research Training Environment (NOT-GM-21-023) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements to Enhance Program Evaluation Capacity (NOT-GM-21-024) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Enhance Undergraduate Biomedical Research Training (NOT-GM-21-025) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Promote Safe and Inclusive Biomedical Research Training Environments (NOT-GM-21-026) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements to Enhance Laboratory Safety Curriculum and a Culture of Safety in Biomedical Research Training Environments (NOT-GM-21-027) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements to Support Undergraduate Summer Research Experiences (NOT-GM-21-028) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for NIGMS-funded Center and Core Facilities (NOT-GM-21-029) National Institute of General Medical Sciences Notice of Special Interest (NOSI): Administrative Supplements for Equipment Purchases for NIGMS R01, R35, and R37 Awardees (NOT-GM-21-030) National Institute of General Medical Sciences Notice of Special Interest (NOSI): NIMH Administrative Supplement Program to Enable Continuity of Research Experiences of MD/PhDs during Clinical Training (Admin Supp Clinical Trial Optional) (NOT-MH-21-150) National Institute of Mental Health Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for the Clinical and Translational Science Award (CTSA) Program to Address COVID-19 Public Health Needs (NOT-TR-21-022) National Center for Advancing Translational Sciences Funding Opportunities Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed) (PAR-21-147) National Institute of General Medical Sciences Application Receipt Date(s): May 26, 2021; May 26, 2022; May 26, 2023 NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed) (PAR-21-149) National Institute of Neurological Disorders and Stroke Application Receipt Date(s): May 25, 2021, May 25, 2022, May 25, 2023 The Midlife in the United States Study (U19 Clinical Trial Not Allowed) (PAR-21-156) National Institute on Aging Application Receipt Date(s): April 26, 2021 and November 18, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date The Midlife in the United States Study - Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed) (PAR-21-157) National Institute on Aging Application Receipt Date(s): April 26, 2021, November 18, 2021 Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) (RFA-DA-22-010) National Institute on Drug Abuse Application Receipt Date(s): October 25, 2021, October 25, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed) (RFA-DE-22-001) National Institute of Dental and Craniofacial Research Application Receipt Date(s): July 26, 2021 Lung Transplant Consortium - Clinical Centers (U01 - Clinical Trial Not Allowed) (RFA-HL-22-002) National Heart, Lung, and Blood Institute Application Receipt Date(s): June 15, 2021 Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed) (RFA-HL-22-003) National Heart, Lung, and Blood Institute Application Receipt Date(s): June 15, 2021 Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Clinical Centers (Collaborative UG3/UH3 Clinical Trial Required) (RFA-HL-22-007) National Heart, Lung, and Blood Institute National Institute on Minority Health and Health Disparities Office of Disease Prevention Office of Research on Women's Health Application Receipt Date(s): June 11, 2021 Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) Multisite Resource and Coordinating Center (U24 Clinical Trial Required) (RFA-HL-22-008) National Heart, Lung, and Blood Institute National Institute on Minority Health and Health Disparities Office of Disease Prevention Office of Research on Women's Health Application Receipt Date(s): June 11, 2021 Mental Health Research Awards for Investigators Early in their Career in Low and Middle-Income Countries (R01 Clinical Trial Optional) (RFA-MH-21-120) National Institute of Mental Health Application Receipt Date(s): November 15, 2021 NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Coordination and Evaluation Center (U24 Clinical Trial Not Allowed) (RFA-RM-21-019) Office of Strategic Coordination (Common Fund) Application Receipt Date(s): April 23, 2021 NIH Funding Opportunities now available in RSS (Really Simple News Syndication) format - click here for details. To UnSubscribe to the NIH Guide Weekly TOC LISTSERV, follow the instructions here. This weekly list can be found here. To join or leave the NIBIB Listserv, please visit this webpage and complete the online form. You can also change your options for the Listserv at this site.

HOME  |  DISCLAIMER  |  POLICIES  |  ACCESSIBILITY  |  FOIA  |  NEWS  |  CONTACT US

SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

---

This email was sent to edwardlorilla1986.paxforex@blogger.com using GovDelivery Communications Cloud, on behalf of: National Institute for Biomedical Imaging and Bioengineering · 9000 Rockville Pike, Building 31, Room 1C14, Bethesda, MD 20892